Apokyn
NDC Package 15054-0211-5

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Apokyn is a medication used to treat the symptoms of Parkinson's disease. Marketed by Tercica, Inc., this product is identified by NDC 15054-0211 and is authorized under FDA application NDA021264.

Identification & Billing

NDC Package Code
15054-0211-5
Package Description
5 CARTRIDGE in 1 CARTON / 3 mL in 1 CARTRIDGE (15054-0211-1)
Product Code
11-Digit Billing Format
15054021105
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Apokyn
Dosage Form
-
Usage Information
This medication is used to treat the symptoms of Parkinson's disease. It can improve your ability to move during frequent "off" periods. It can decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. This medication is thought to work by helping to restore the balance of a certain natural substance (dopamine) in the brain. Apomorphine is used to treat "off" episodes when they occur. It is not used to prevent "off" episodes. This drug should not be used instead of your usual medications for Parkinson's disease. Continue taking all your medications as directed by your doctor.

Regulatory & Marketing

Labeler Name
Tercica, Inc.
FDA Application #
NDA021264
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-02-2004
End Marketing Date
10-31-2011
Listing Expiration
10-31-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 15054-0211-5 identifies a specific commercial package of 5 cartridge in 1 carton / 3 ml in 1 cartridge (15054-0211-1) of Apokyn, labeled by Tercica, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tercica, Inc. on July 02, 2004. The current certification is valid through October 31, 2011.

What are the primary indications for this medication?

This medication is used to treat the symptoms of Parkinson's disease. It can improve your ability to move during frequent "off" periods. It can decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. This medication is thought to work by helping to restore the balance of a certain natural substance (dopamine) in the brain. Apomorphine is used to treat "off" episodes when they occur. It is not used to prevent "off" episodes. This drug should not be used instead of your usual medications for Parkinson's disease. Continue taking all your medications as directed by your doctor.

How is this Tercica, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 15054021105. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
15054-0211-5
11-Digit CMS (5-4-2)
15054-0211-05

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.